 The AOTI two2 therapy trial is a randomized, double-blinded, parallel group, placebo-controlled, multi-center study intended to evaluate the efficacy of Topical Wound Oxygen two2 therapy in relation to placebo when added to standard of care in the treatment of diabetic lower extremity ulcers. 